Miss Betty
Address:
Rm 1703, No#8, Fsv Mansion, No. 1679 Ningchuan Rd, Ningbo, Zhejiang, China
Telephone:
Zip Code:
Fax:
Please sign in to view contact details |
Account Registered in:
2020
Business Range:
Agriculture & Food, Chemicals
Management System Certification:
ISO 9001
Business Type:
Manufacturer/Factory
Company Introduction
Trade Capacity
Production Capacity
We serve customers in China and abroad by providing high quality, matchless material with competitive price. And we also recommending reliable manufacturers with competitive price&highest quality service, STABLE supply. Quality is the cornerstone for enterprises to survive.
We focus on chemicals Generic API (including their intermediates), Innovative compounds, key starting materials and ...
We focus on chemicals Generic API (including their intermediates), Innovative compounds, key starting materials and ...
We serve customers in China and abroad by providing high quality, matchless material with competitive price. And we also recommending reliable manufacturers with competitive price&highest quality service, STABLE supply. Quality is the cornerstone for enterprises to survive.
We focus on chemicals Generic API (including their intermediates), Innovative compounds, key starting materials and advanced intermediates.
WHAT WE HAVE?
Presently we have 1 own R&D centre(Specialized on Tyrosine kinase inhibitor -tinib type product, It covers an area of 1000 Sq. 20 R&D personnel, 3 QA, 4 QC );
One own manufacturing site(Located at Touzeng chemical area, Binghai district, Jiangsu (It covers 25000 Sq. 61 workers, have commercialized around 50 products for R$D centre);
Two strategic partnership manufacturing sites: 1 GMP & 1 FDA manufacturing site. The site passed audit for advanced intermediates and APIs from authorities like SFDA; They both passed frequent EHS & Quality audit from top ranking companies.
WHAT WE EXTRA DO?
We also do CMO project for customers. Up to now, we has developed and commercialized for more than 100 new drug intermediates, and has established a long cooperation in many well-known domestic pharmaceutical enterprises.
DOCUMENTATION
We have one manager who is experience in all kind of documentation support, such as VQ documentation, Tech Pack documentation, etc.
We focus on chemicals Generic API (including their intermediates), Innovative compounds, key starting materials and advanced intermediates.
WHAT WE HAVE?
Presently we have 1 own R&D centre(Specialized on Tyrosine kinase inhibitor -tinib type product, It covers an area of 1000 Sq. 20 R&D personnel, 3 QA, 4 QC );
One own manufacturing site(Located at Touzeng chemical area, Binghai district, Jiangsu (It covers 25000 Sq. 61 workers, have commercialized around 50 products for R$D centre);
Two strategic partnership manufacturing sites: 1 GMP & 1 FDA manufacturing site. The site passed audit for advanced intermediates and APIs from authorities like SFDA; They both passed frequent EHS & Quality audit from top ranking companies.
WHAT WE EXTRA DO?
We also do CMO project for customers. Up to now, we has developed and commercialized for more than 100 new drug intermediates, and has established a long cooperation in many well-known domestic pharmaceutical enterprises.
DOCUMENTATION
We have one manager who is experience in all kind of documentation support, such as VQ documentation, Tech Pack documentation, etc.
International Commercial Terms(Incoterms):
FOB, CFR, CIF
Terms of Payment:
LC, T/T
Number of Foreign Trading Staff:
4~10 People
Export Year:
2020-04-26
Export Percentage:
51%~70%
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia, Western Europe
Nearest Port:
shanghai
qingdao
qingdao
Import & Export Mode:
Have Own Export License
Export License Number: | 02856168 |
---|---|
Export Company Name: | Ningbo Eshine Pharmaceutical Co.,Ltd |
License Photo:
Factory Address:
Rm 1703, No#8, Fsv Mansion, No. 1679 Ningchuan Rd, Ningbo, Zhejiang, China
R&D Capacity:
OEM, ODM, Own Brand()
No. of R&D Staff:
11-20 People
No. of Production Lines:
2
Annual Output Value:
US$2.5 Million - US$5 Million